Research LettersSurvival after introduction of HAART in people with known duration of HIV-1 infection
References (4)
- et al.
Changing patterns of mortality across Europe in patients infected with HIV-1
Lancet
(1998) Seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a pooled cohort analysis
Lancet
(2000)
Cited by (198)
Analysis of the impact of treatments on HIV/AIDS and Tuberculosis co-infected population under random perturbations
2024, Infectious Disease ModellingOcular syphilis
2022, Survey of OphthalmologyAntiretroviral drug-induced endothelial dysfunction is improved by dual PPARα/γ stimulation in obesity
2019, Vascular PharmacologyCitation Excerpt :However, these characteristics were attenuated following Saroglitazar co-treatment with HAART in obese animals. Current trends indicate that non-AIDS-related cardiometabolic events are emerging as a major health burden in HIV-infected populations [36]. The pathophysiological mechanisms underlying these events are still incompletely understood because specific organ disturbances are multifactorial in aetiology.
Optimal timing for elective total hip replacement in HIV-positive patients
2018, Orthopaedics and Traumatology: Surgery and ResearchKnee extension and flexion strength asymmetry in Human Immunodeficiency Virus positive subjects: a cross-sectional study
2017, Brazilian Journal of Physical TherapyCitation Excerpt :The human immunodeficiency virus (HIV) attacks the immune system of its host and may cause acquired immunodeficiency syndrome (AIDS). However, the course of the HIV infection changed dramatically with the introduction of highly active antiretroviral therapy (HAART), which reduced patient mortality and morbidity and transitioned AIDS from an acute to a chronic disease.1 In a 2010 study, an examination of the specific causes of mortality in HIV-positive patients found that only 49.5% of deaths were AIDS-related, and the proportion of deaths classified as AIDS-related decreased with increasing duration of HAART.2
Mid-term outcomes in HIV-positive patients after primary total hip or knee arthroplasty
2014, Journal of Arthroplasty